VANCOUVER, British Columbia, June 1, 2023 -- Biocure Technology Inc. (“Biocure” or the “Company”) (CSE:CURE) announces today, further to its press releases dated December 19, 2022, that it has executed an agreement dated December 16, 2022, February 8, 2023, February 24, 2023 and May 18, 2023, the Company has the sale of 1,773,879 common shares and 57,954 preferred shares of BiocurePharm Corporation (“BPK”) held by the Company to CEO, Dr. Sang Mok Lee and the cancellation of an aggregate of 27,317,506 common shares of the Company held by Dr. Lee as consideration for the BPK securities (the “Transaction”). Following completion of the Transaction, the Company now has 81,603,652 common shares outstanding and Dr. Lee now no longer holds any securities of the Company other than 1,000,000 stock options with an exercise price of $0.30 and an expiry date of February 16, 2024.

Dr. Lee will continue to remain as the Company’s CEO and a director pending the completion of certain post-closing filings in Korea.

ON BEHALF OF THE BOARD OF DIRECTORS

/S/ “SANG MOK LEE”
CEO and Director

For further information, please contact:

Biocure Technology Inc. Telephone: 604-609-7146, or This email address is being protected from spambots. You need JavaScript enabled to view it.

PRESS RELEASE ON PDF

Certain statements in this news release, which are not historical in nature, constitute “forward looking statements” within the meaning of that phrase under applicable Canadian securities law. These statements include, but are not limited to, statements or information concerning the Company’s proposed activities under the Agreement and the expectations of the Company regarding funding payments due pursuant to the Agreement. These statements reflect management’s current assumptions and expectations and by their nature are subject to certain underlying assumptions, known and unknown risks and uncertainties and other factors which may cause actual results, performance or events to be materially different from those expressed or implied by such forward looking statements. Except as required pursuant to applicable securities laws, the Company will not update these forward- looking statements to reflect events or circumstances after the date hereof. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by the Company. Readers are cautioned not to place undue reliance on forward looking statements.